Advertisement

Related Videos

Welcome and Introduction to Vi3C

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Jul
10
Today In Oncology
Zanidatamab Plus Chemotherapy in Advanced HER2-Positive Gastroesophageal Adenocarcinoma
Women Aged 65 Plus Still at Heightened Risk of HPV-Related Cervical Cancer
Corticosteroids May Limit Efficacy of Immunotherapy in Patients With NSCLC
Optimizing the CAR to the Disease in B-Cell Malignancies
Study Supports Multi-Contaminant Water Treatment to Reduce Cancer Risk
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo